{"altmetric_id":2347148,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["ViralPseudotype","digitalsci"],"posts_count":2}},"citation":{"altmetric_jid":"figshare","authors":["Nigel Temperton","Nigel, Temperton"],"doi":"10.6084\/m9.figshare.1024505","first_seen_on":"2014-05-13T11:23:01+00:00","issns":[],"journal":"figshare","last_mentioned_on":1399980424,"links":["http:\/\/figshare.com\/articles\/Viral_Pseudotype_Unit_Pseudovirus_serologics_and_pharmacologics\/1024505"],"pdf_url":"http:\/\/files.figshare.com\/1495009\/Viral_Pseudotype_Unit_for_kentscifest_2014.pdf","pubdate":"2014-05-13T11:20:31+00:00","title":"Viral Pseudotype Unit Pseudovirus serologics and pharmacologics","type":"dataset"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4508612,"mean":5.1916753366762,"rank":2280566,"this_scored_higher_than_pct":36,"this_scored_higher_than":1654000,"rank_type":"exact","sample_size":4508612,"percentile":36},"similar_age_3m":{"total_number_of_other_articles":107824,"mean":7.7893109818871,"rank":52016,"this_scored_higher_than_pct":38,"this_scored_higher_than":41855,"rank_type":"exact","sample_size":107824,"percentile":38},"this_journal":{"total_number_of_other_articles":7210,"mean":4.3238424191982,"rank":4201,"this_scored_higher_than_pct":26,"this_scored_higher_than":1946,"rank_type":"exact","sample_size":7210,"percentile":26},"similar_age_this_journal_3m":{"total_number_of_other_articles":16,"mean":11.565733333333,"rank":14,"this_scored_higher_than_pct":6,"this_scored_higher_than":1,"rank_type":"exact","sample_size":16,"percentile":6}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}}},"geo":{"twitter":{"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ViralPseudotype\/status\/466176664553017346","license":"datasift","citation_ids":[2347148],"posted_on":"2014-05-13T11:22:32+00:00","author":{"name":"ViralPseudotypeUnit","url":"http:\/\/www.viralpseudotypeunit.info","image":"https:\/\/pbs.twimg.com\/profile_images\/751539087174164480\/nUlGI38o_normal.jpg","description":"The VPU is an R&D laboratory headed by Nigel Temperton, Simon Scott and @edwardwrightuk with expertise in developing pseudotype-based immunogenicity assays","id_on_source":"ViralPseudotype","tweeter_id":"518659141","geo":{"lt":51.38764,"ln":0.50546,"country":"GB"},"followers":839},"tweet_id":"466176664553017346"},{"url":"http:\/\/twitter.com\/digitalsci\/status\/466177803852214272","license":"datasift","rt":["ViralPseudotype"],"citation_ids":[2347148],"posted_on":"2014-05-13T11:27:04+00:00","author":{"name":"Digital Science","url":"http:\/\/www.digital-science.com","image":"https:\/\/pbs.twimg.com\/profile_images\/458896241846276097\/LgO-Xmnx_normal.png","description":"A technology company serving the needs of scientific and research communities.","id_on_source":"digitalsci","tweeter_id":"144972081","geo":{"lt":null,"ln":null},"followers":22377},"tweet_id":"466177803852214272"}]}}